Drugs / HGR4113
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05642377 | Nov 2022 → Jul 2024 | type 2 diabetes mellitus | Glaceum | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HGR4113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05642377 ↗ |
| Modality | Small molecule | — CHEMBL5314957 ↗ |
| Route | Oral | “Once-daily oral administration” NCT05642377 ↗ |